ID: ALA108023

Max Phase: Preclinical

Molecular Formula: C6H12FNO3

Molecular Weight: 165.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC[C@H]1NC[C@@H](F)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C6H12FNO3/c7-3-1-8-4(2-9)6(11)5(3)10/h3-6,8-11H,1-2H2/t3-,4-,5-,6-/m1/s1

Standard InChI Key:  KXZREBFWDJJIRA-KVTDHHQDSA-N

Associated Targets(Human)

Beta-glucocerebrosidase 14647 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-mannosidase 2C1 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 165.16Molecular Weight (Monoisotopic): 165.0801AlogP: -1.99#Rotatable Bonds: 1
Polar Surface Area: 72.72Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.75CX Basic pKa: 7.13CX LogP: -1.99CX LogD: -2.18
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.36Np Likeness Score: 1.62

References

1. Berger A, Dax K, Gradnig G, Grassberger V, Stutz A, Ungerank M, Legler G, Bause E.  (1992)  Synthesis and biological activity of C-6 modified derivatives of the glucosidase inhibitor 1-deoxynojirimycin.,  (1): [10.1016/S0960-894X(00)80648-4]

Source